Unicycive Therapeutics, Inc.
Public company- Headquarters
- MOUNTAIN VIEW, California
- Ticker
- UNCY
- CIK
- 0001766140
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| independent director on the Company’s board of directorsMeredith S. Manning | Sep 29, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- ACADIA PHARMACEUTICALS INC
Executive Vice President, Head of Research and Development departs: Elizabeth H.Z. Thompson, Ph.D.
- KYNTRA BIO, INC.
Class III director appointed: Andrew E. Singer, MBA
- BIOMARIN PHARMACEUTICAL INC
WARN notice: Novato, CA
- CORCEPT THERAPEUTICS INC
President of Corcept Endocrinology departs: Sean Maduck
- Executive appointment
independent director on the Company’s board of directors appointed: Meredith S. Manning
Meredith S. Manning was named independent director on the Company’s board of directors of Unicycive Therapeutics, Inc., effective October 1, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 29, 2026Role: independent director on the Company’s board of directors
Only one public record so far. We add events as soon as a new filing lands; watch Unicycive Therapeutics, Inc. to get them in your digest.
Last verified Nov 8, 2026